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Background: The issue of when, how, and whether to disclose full information about cancer 
diagnosis and prognosis to patients is still debated in some parts of the world, including Lebanon. 
Despite formal academic emphasis on a larger autonomy for Lebanese patients in deciding the 
course of their disease, there has been no apparent impact on either clinical practices nor public 
expectations.  The topic of full disclosure is rarely if ever discussed in open fora, or in mass media 
channels in Lebanon.   
Subjects and Method: Seven key stakeholders were identified and interviewed regarding 
obstacles to spelling out clear guidelines within our national context. The interviews were 
transcribed and subsequently analyzed for recurrent patterns and concepts.  
Results: Senior oncologists interviewed generally favored gradual disclosure and most perceived a 
changing trend among both patients and physicians towards more disclosure. They also agreed on 
a need for the formal training of residents and fellows to better communicate bad news to patients. 
All the interviewed physicians attested to the benefits of candid disclosure in terms of patient 
psychology and overall wellbeing. They also mentioned that psychological services, which may 
facilitate the disclosure process, are greatly under-utilized in oncology. Lawyers highlighted the 
vagueness of the current Lebanese legislation regarding the obligation of truthful disclosure in 
comparison to laws in developed countries and the implications on patient autonomy.   
Conclusion: The study identified the need for improvements at various levels, including 
interventions to modify the expectations of the Lebanese public regarding cancer disclosure and to 
clarify existing legislative texts. 
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Despite progress in cancer prognosis, get-
ting a full diagnosis still overwhelms pati-
ents and family members both physically 
and mentally (Kazdaglis et al., 2010; Dégi, 
2009). Different countries approach disclo-
sure differently (Mystakidou et al., 2004). 
Currently, acknowledgment of the disease 
is the norm in many developed countries 
including most of Europe and North Ame-
rica. In such regions, patient autonomy 
takes precedence, and laws support the 
moral obligation of truth telling (Wood et 
al., 2009).  On the other hand, the issue of 
when, how, and whether to disclose full or 
partial information about diagnosis and 
prognosis to cancer patients is still disputed 
in some traditional countries such as 
Japan, Greece, Italy, Turkey, and Lebanon 
(Elwyn et al., 2002; Tsoussis et al., 2013; 
Grassi et al., 2000; Oksüzoğlu et al., 2006; 
Naji et al., 2015). In the Middle Eastern 
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culture, families play a large intermediate 
role in receiving the information, transla-
ting it to the patient, and discussing thera-
peutic options with the providers (Khalil, 
2013). Their views are “strongly tied to 
social norms and traditions” that resist the 
“western conception” of full and direct 
disclosure (Surbone, 2006).  
The issue of disclosure has been 
considered from several angles in Lebanon 
since the 1990s.  In a study conducted in 
1998 among physicians likely to encounter 
cancer cases in their practice, 47% usually 
disclosed the truth to cancer patients. The 
tendency to disclose was strongly asso-
ciated with older practitioners with length-
ier clinical experience and with providers of 
specialized surgical or medical care rather 
than primary health care (Hamadeh and 
Adib, 1998). A more recent study in 2015 
showed that not much had changed in the 
preference for consistent disclosure in 
almost two decades.  In that paper, “83% of 
physicians in Lebanon preferred disclosing 
diagnosis and prognosis to their patients.  
However, only 40% revealed the true diag-
nosis to the patients themselves and just 
9% disclosed the information immediately 
after the diagnosis is known" (Farhat et al., 
2015).  
Concerning preferences in the public, 
a 1999 study showed that 42% of respon-
dents preferred not having the truth about 
serious diseases fully disclosed to patients 
(Adib and Hamadeh, 1999). This study 
predicted that as the Lebanese public's level 
of awareness about the effectiveness of 
medicine increases, the expectations for 
concealment will decrease (Adib and Ha-
madeh, 1999). However, the expectations 
may be different when cancer becomes a 
reality and not just a hypothetical possi-
bility.  In 2015, 80% of relatives of cancer 
patients in Lebanon declared not being in 
favor of revealing detailed information 
about the disease to the patient directly. 
Physicians, being aware of this, tend to 
inform the family first about a cancer 
diagnosis, seeking their approval regarding 
the degree of information to be provided to 
the patient (Farhat et al., 2015).  
The Lebanese legislation upholds the 
right of patients to be completely informed 
about their diagnosis, the proposed mana-
gement plan, the existence of therapeutic 
options, and the disease prognosis. It also 
binds the doctor to disclose to patients all 
the information concerning their disease. 
However, if the patient does not wish to be 
informed, then these wishes must be res-
pected. Under such circumstances, the 
patient can appoint a representative to be 
informed of the condition and treatment 
plan.  In addition, if it were established that 
the disclosure of the diagnosis would carry 
a negative impact on the patient and the 
course of treatment, then the doctor can 
exceptionally reveal the information gra-
dually for the patient’s benefit (Law 574, 
2004). 
Despite formal academic emphasis on 
a larger autonomy for Lebanese patients in 
deciding the course of their disease, there 
has been no apparent impact on neither 
clinical practices nor public expectations.  
The topic of full disclosure is rarely if ever 
discussed in open fora, or in mass media 
channels in Lebanon. In this qualitative 
paper, we have interviewed several medical 
and non-medical stakeholders to obtain 
their views regarding the changing patterns 
of disclosure behavior or the absence 
thereof in Lebanon as we approach 2020. 
 
SUBJECTS AND METHOD 
1. Study design 
Domains of factors influencing disclosure 
of diagnosis/prognosis to cancer patients 
were identified based on a thorough litera-
ture review and after consulting with medi-
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cal experts. These were: physician-patient 
interaction, psychological support in disclo-
sure, and legislation regarding medical con-
duct. Key stakeholders with expert know-
ledge in any one of those domains were 
determined and interviewed.  
2. Sources of data 
Seven key stakeholders were interviewed. 
They included three foreign-trained onco-
logists working at the American University 
of Beirut Medical Center (AUBMC) and one 
working at the Military Hospital in Beirut. 
One interview was conducted with a 
foreign-trained psychiatrist working at 
AUBMC. A lawyer with training in inter-
national law currently practicing in and 
around the capital city Beirut was identified 
to discuss legal aspects of the issue.  Finally, 
an interview was conducted with a Member 
of Parliament (MP) who had been serving 
as Chairman of the Health Committee for 
more than 15 years. Given that the vast 
majority of cancer patients in Lebanon 
ended up being treated in the Greater 
Beirut area, the stakeholders selected 
offered a representative view of cancer 
disclosure practice in Lebanon. 
3. Procedures  
All interviews were scheduled in the fall of 
2017 via email, with an explanation of the 
purpose and structure of the encounter.  
They were conducted face-to-face by mem-
bers of the research team. A semi-struc-
tured format was used, which included the 
same set of core open questions and other 
variable ones tailored to the domain of 
expertise of each stakeholder. The inter-
views were transcribed and subsequently 








1. Aspects of physician-patient inter-
action affecting disclosure 
These aspects include the physicians’ 
current practice of disclosure, perceived 
trends in disclosure in Lebanon, and the 
effect of their training as medical resi-
dents/fellows on their preferred attitude. 
Based on personal experience, all the 
oncologists interviewed were proponents of 
open disclosure, when possible. Most would 
routinely ask the patients, prior to any inva-
sive investigation, how much they would 
like to know about a suspected cancer.  All 
concurred that the method of disclosure is 
of prime importance. In general, they 
would favor a gradual disclosure of the 
severity of the disease that takes place over 
several visits. One physician regretted that 
some oncologists rush through the dis-
closure process before a firm relationship 
has been established with a patient. The 
wording used for the disclosure was also a 
key point emphasized by most interviewees. 
One oncologist mentioned: “At times I do 
not use the word cancer, but try to deliver 
the news using different terms such as 
“severe inflammation” instead of cancer 
and “IV medication” instead of chemo-
therapy”. Another mentioned that when 
cancer is described as a “chronic” rather 
than a “terminal” illness, the patient 
accepts the diagnosis more readily. 
Three of the interviewed oncologists 
mentioned that in their experience, trends 
in cancer disclosure seem to be changing. 
They perceived that patients were gradually 
shifting towards more demand for auto-
nomy and more desire for full knowledge. 
They noticed that this was a salient feature 
particularly in younger patients.  The three 
oncologists practicing at AUBMC mention-
ed that disclosure is becoming the norm in 
their practices, while one oncologist work-
ing in another non-University affiliated 
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facility, regretted that he did not perceive 
such trends towards truthful disclosure 
occurring around him. 
All the oncologists reported that they 
had received no formal training in commu-
nication skills needed for breaking bad 
news during their medical education or 
training in Lebanon. They confirmed that 
such training would have facilitated their 
choice for routine disclosure.  Although the 
foreign-trained oncologists mentioned that 
disclosure was mandatory in their training, 
they admitted that they did not always 
transmit the line of conduct recommended 
elsewhere to their Lebanese trainees due to 
the “peculiarities of the region”. Only one of 
the oncologists seemed to have adopted a 
systematic pattern for breaking bad news, 
when he deemed it possible or desirable.   
All physicians interviewed, including the 
psychiatrist visited for the purposes of this 
research, highlighted the importance of 
integrating a formal communication skills 
course specific for breaking cancer news in 
training curricula in the Middle-East.  
Other than disclosing cancer diagnosis, 
physicians mentioned training to approach 
all potentially heavy issues such as the 
discussion of the “do not resuscitate/do not 
intubate” option and preferences for 
palliative/end-of-life care. 
2. Psychological support in 
disclosure 
The oncologists were asked about the 
psychological dimensions of full outcome 
disclosure and the utility of psychological 
services. All the interviewed oncologists 
attested to the benefits of candid disclosure 
on patients’ psychological wellbeing in their 
practice. They mentioned that patients who 
receive full disclosure become more coope-
rative and receptive to the physician’s 
options for care.  They also noticed that the 
elimination of uncertainty alleviates some 
of the patients’ fear and allows them to 
better cope with their symptoms. They 
noted that distrust often arises when dis-
closure is delayed, which compromises the 
quality of care delivered.  
The psychiatrist believed that unless 
patients explicitly refuse disclosure, it is 
always better for their psychological health 
to know their diagnosis. In addition, he 
mentioned the importance of using the 
proper language on patients’ psychology. 
Words that convey empathy and hold less 
negative connotations can make a big 
difference in how the news are received: 
“The more control you have over a situa-
tion, the better your state of mind. We can 
always find a way to deliver the diagnosis 
in a manner suitable to the patient’s level 
of education and understanding”. The psy-
chiatrist mentioned that patients would be 
undergoing state-of-the art treatment while 
their mental health needs were being neg-
lected. Depression, anxiety, and PTSD are 
some of the co-morbidities that might sur-
face with a new cancer diagnosis and later 
during the long and uncertain treatment 
process. He indicated that psychological 
services were greatly under-utilized in 
oncology in Lebanon, perhaps because 
oncologists feel they are capable of hand-
ling psychological outcomes and prescrib-
ing psychotropic medications on their own. 
Yet, “the oncologist might have a huge 
patient load and might not give sufficient 
time for the patient to absorb the news. 
Here comes the role of the psychological or 
the palliative care team to intervene and 
offer support as needed. It is even better 
for the patient to have a psychologist 
involved at the time of disclosure.” Some 
oncologists, speaking for the record, 
emphasized the need for having a psycho-
logist as part of the multidisciplinary team 
taking care of cancer patients who would 
“dedicate time to listen to them, comfort 
them, and assess their psychological state.” 
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3. Legislation regarding medical 
conduct 
All the oncologists interviewed were not 
aware of any obligation to disclose under 
the Lebanese law. They could not accurately 
articulate what was permitted or expected 
of them in the Lebanese legislation. They all 
agreed that no institutional policy exists 
about truthful disclosure of diagnosis/ 
prognosis to patients at AUBMC or the 
Military Hospital.  The team sought out the 
AUBMC Administration, which confirmed 
that this was actually the case. 
The research team met the physician 
serving as Chair of the Health Commission 
in the Lebanese Parliament.   He pointed to 
the “Right to Medical Care in Lebanon” law 
574/2004, which had been enacted and 
never amended since then. The MP was 
willing to discuss shortcomings in the law 
to be considered for eventual modifications. 
“It is now brought to my attention even 
more how in practice, disclosing the 
diagnosis of cancer is not an easy task. It is 
not easy for the doctor to disclose nor is it 
easier to conceal information from 
patients. I think there is a great need for 
psychological support in determining 
patient readiness concerning disclosure 
and offering necessary support during 
treatment. Maybe this new idea can be 
formulated and added to the law.” 
  
DISCUSSION 
1. Physician-patient interaction 
The results of our study confirm that key 
stakeholders do not perceive the current 
practices as consistent and codified.  This is 
similar to the findings of previous Lebanese 
studies. Failure to meet patients’ expecta-
tions can be attributed to several social, 
legal, and psychological factors.  
The use of misleading wordings to 
describe cancer is alarming. These “in-
correct” wordings can be widely misinter-
preted and actually impede the optimal 
management course of a cancer case.  This 
practice is in direct opposition to the 
concept of informed consent and patient 
autonomy, setting a fertile ground for dis-
trust to arise in the physician-patient rela-
tionship. In India, one study showed that 
several euphemisms are used to replace the 
word cancer early on in disclosure inclu-
ding “tumor”, “growth”, and “lump” (Chit-
tem, 2015). Even such words were cons-
trued by some oncologists of the study as a 
dilution of the message, which in effect 
constitutes lying (Chittem, 2015).  
Considering the difficulty of commu-
nicating dismal prognoses to patients, 
medical guidelines on breaking bad news 
have been published, such as the SPIKES 
protocol (Baile et al., 2000; Girgis and 
Sanson-Fisher, 1995). Several strategies, 
including didactic lectures and group dis-
cussions, have been developed to teach 
medical students and physicians the 
methodology of communicating bad news 
(Rosenbaum et al., 2004). In addition, the 
incorporation of standard disclosure train-
ing into curricula has been shown to be 
beneficial for trainees (Baile et al., 1999). A 
survey sent to all the hematology/ oncology 
fellowship program directors in the US 
showed that 63% felt that extensive, formal 
training is important for skill development 
in delivering bad news while only 23% of 
their fellows actually received considerable 
training (Hebert et al., 2009). In line with 
these views, most of the stakeholders in our 
study see great benefit in formally teaching 
Lebanese fellows and residents the art of 
breaking bad news. The Order of Physicians 
in Lebanon, which holds the ultimate 
corporate control on medical practice and is 
consulted regarding all new health-related 
legislation, should play a leading role with 
program directors to incorporate a formal 
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and structured training program for 
trainees and attending physicians alike. 
2. Norms and awareness 
Most practitioners attribute the inconsist-
ent practices and tendency to withhold 
truth to alleged expectations in the Leba-
nese public.  It is very likely that the preva-
lent traditional culture, which values “keep-
ing hope alive” as a sign of protecting the 
patient’s well-being, will indeed resist full 
disclosure (Adib, 2004). However, this 
normative denial attitude is based on 
obsolete knowledge and awareness regard-
ing cancer prognosis. A 2016 survey of 
public awareness about malignancy in 
India, another traditional culture, illustra-
ted that 30% of responders were unaware 
that cancer can be curable, that it is not 
contagious, and that it is not a curse or 
death sentence (Elangovan et al., 2016). No 
studies have been done in Lebanon to 
gauge the public’s awareness and percept-
ion of cancer in the modern era of persona-
lized therapy, very likely because inter-
ventions targeting awareness have not been 
attempted. As more knowledge is dissemi-
nated regarding the treatability and 
improved outcomes in cancer, expectations 
should change, prompting modifications in 
physicians’ disclosure practices.  
3. Role of psychology in disclosure 
Psycho-oncology, which emerged about 30 
years ago, has “produced a model in which 
the psychological domain has been inte-
grated, as a subspecialty, into the disease-
specific specialty of oncology” (Holland and 
Weiss, 2010). The field offers many contri-
butions to training staff in psychological 
management, taking care of patients and 
their families, and adding to the existing 
body of research (Holland and Weiss, 
2010). Confirming the benefit of having 
psycho-oncologists as integrated members 
of the healthcare team, an Italian study 
showed that cancer patients receiving 
chemotherapy with ancillary psychological 
services had lower anxiety levels, adapted 
better to their illness, and had higher 
overall health-related quality of life accord-
ing to objective self-rating scales (Pugliese 
et al., 2006). There is ample opportunity to 
improve the cross-talk between psycho-
logists and Oncology departments in Leba-
nese hospitals, as there is agreement 
between stakeholders from both fields that 
these two disciplines are complementary.  
4. Law 
Stakeholders associated with the legal 
context spoke about the vagueness of the 
current Lebanese legislation when it comes 
to truthful disclosure. What is the time-
frame of “gradually” revealing information? 
How can a physician objectively determine 
when a diagnosis will carry a stressful toll 
on the patient? The law reflects great 
uncertainty as to what constitutes sound 
medical practice. On the one hand, it 
mandates truthful disclosure of all infor-
mation to patients; on the other, it states 
that certain exceptions can be present 
without clearly delineating these except-
ions. A good benchmark for legal obli-
gations can be seen in the US bill of rights 
outlining what people being treated for all 
illnesses should expect to receive from their 
hospitals, doctors, and nurses. It clearly 
mentions that “patients should be given 
complete, accurate information in straight 
forward language about their diagnosis, 
prognosis, and treatment plan” (American 
Hospital Association, 1992).  We call upon 
medical practitioners directly involved with 
cancer patients to be advocates for re-
writing the current law, to reduce the 
opportunity for subjective interpretation 
and to enforce the obligation of empower-
ing patients with full knowledge.  The issue 
of disclosure should continue to be moni-
tored as laws and norms change in Lebanon 
and neighboring countries. 
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